In focus · trending topic

psoriasis

18 stories · following the connections

Novan Presents Preclinical Data from Inflammatory Skin Diseases Program

By Nasdaq OMXApr 27, 2017, 1:05 PM UTC

Galectin’s GR-MD-02 Demonstrates Efficacy in Patients with Moderate to Severe Plaque Psoriasis

By Nasdaq OMXMar 6, 2017, 1:31 PM UTC

Galectin’s GR-MD-02 Demonstrates Efficacy in Patients with Moderate to Severe Plaque Psoriasis

By Nasdaq OMXMar 6, 2017, 1:31 PM UTC

Dermira to Report Fourth Quarter and Full Year 2016 Financial Results

By Nasdaq OMXFeb 22, 2017, 9:36 PM UTC

Novan Announces Preclinical Data Demonstrating Immunomodulatory Effect In Vivo

By Nasdaq OMXNov 16, 2016, 2:05 PM UTC

Galectin Therapeutics to Present Clinical Data on Selective Non-Invasive Tests for the Development of Novel Therapies for Nonalcoholic Steatohepatitis

By Nasdaq OMXOct 7, 2016, 12:30 PM UTC

Galectin Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment Conference

By Nasdaq OMXAug 31, 2016, 12:00 PM UTC

Galectin Therapeutics Announces Results From 12-Week Extension of Phase 2a Psoriasis Clinical Trial

By Nasdaq OMXAug 25, 2016, 12:00 PM UTC